Butylphthalide: A New Drug To Treat Acute Cerebral Arterial Thrombosis Passes Phase III Clinical Trial
This article was originally published in PharmAsia News
Executive Summary
Butylphthalide, independently developed in China, is the world's first drug to treat acute cerebral arterial thrombosis, and CSPC Pharma recently completed Phase III trials for the new drug